IGC Pharma, Inc.IGCNYSE
Loading
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q4 2025 | 62.00% |
| Q3 2025 | -3.63% |
| Q2 2025 | -23.72% |
| Q1 2025 | 33.90% |
| Q4 2024 | -4.42% |
| Q3 2024 | 30.89% |
| Q2 2024 | 25.00% |
| Q1 2024 | 50.29% |
| Q4 2023 | -94.46% |
| Q3 2023 | -15.35% |
| Q2 2023 | 48.42% |
| Q1 2023 | -81.34% |
| Q4 2022 | 8.93% |
| Q3 2022 | 15.00% |
| Q2 2022 | 66.25% |
| Q1 2022 | -243.35% |
| Q4 2021 | 46.44% |
| Q3 2021 | -133.24% |
| Q2 2021 | 47.76% |
| Q1 2021 | -27.05% |
| Q4 2020 | -39.80% |
| Q3 2020 | 14.10% |
| Q2 2020 | 41.65% |
| Q1 2020 | -98.02% |
| Q4 2019 | -35.91% |
| Q3 2019 | 14.61% |
| Q2 2019 | 12.75% |
| Q1 2019 | -36.99% |
| Q4 2018 | -6.57% |
| Q3 2018 | -66.06% |
| Q2 2018 | 12.70% |
| Q1 2018 | 0.00% |
| Q4 2017 | -70.27% |
| Q3 2017 | 33.53% |
| Q2 2017 | 43.00% |
| Q1 2017 | -614.63% |
| Q4 2016 | 83.40% |
| Q3 2016 | -49.70% |
| Q2 2016 | 73.00% |
| Q1 2016 | -146.37% |